GO:0009058 biosynthetic process: Anabolic Pathways, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0009058 biosynthetic process describes the energy-requiring biochemical pathways that build complex molecules from simpler precursors, also known as anabolism or biosynthesis.
• Biosynthetic flux is reprogrammed in metabolic disease and cancer, making it a central target for therapeutic and diagnostic research.
• Biosynthetic pathways span small-molecule synthesis, protein folding, and heterologous production of natural products such as artemisinin.
• Molecular chaperones are required for biosynthetic protein folding, linking the term to proteostasis and disease.
• CRISPR knockout, point-mutation, knock-in, and overexpression models enable causal testing of biosynthetic genes in disease contexts.
• Understanding biosynthetic process regulation informs metabolic engineering, drug discovery, and precision medicine.
Description
The Gene Ontology term GO:0009058, biosynthetic process, defines the biochemical pathways by which living organisms synthesize chemical substances, typically representing the energy-requiring part of metabolism in which simpler substances are transformed into more complex ones. This term encompasses anabolism, biosynthesis, formation, and synthesis, and is fundamental to understanding how cells build the macromolecules and metabolites required for growth, proliferation, and survival. Research on biosynthetic process spans diverse fields, from cancer metabolism to metabolic engineering, because dysregulated biosynthesis is a hallmark of many diseases. For example, cancer cells often rewire biosynthetic pathways to support rapid proliferation, a phenomenon that has been extensively reviewed. Similarly, metabolic diseases such as diabetes and obesity involve altered gluconeogenesis flux, a key biosynthetic process. Beyond human health, biosynthetic process is central to industrial biotechnology, as demonstrated by the semi-synthetic production of the antimalarial artemisinin in engineered yeast. Protein folding, a critical biosynthetic process, ensures that newly synthesized polypeptides attain their native structures, often assisted by molecular chaperones. Thus, GO:0009058 provides a unifying framework for studying how cells and organisms construct their molecular inventory, with broad implications for basic biology and translational research.
biosynthetic process At A Glance
| GO ID | GO:0009058 |
|---|---|
| GO term | biosynthetic process |
| Ontology | biological_process |
| Synonym | anabolism, biosynthesis, formation, multicellular organismal biosynthetic process, single-organism biosynthetic process, synthesis |
| Major function | Synthesis of complex molecules from simpler precursors, requiring energy |
| Related processes | Gluconeogenesis, amino acid synthesis, nucleotide synthesis, protein folding, natural product biosynthesis |
| Research relevance | Cancer metabolism, metabolic disease, biotechnology, drug discovery |
| Key regulatory nodes | mTOR, AMPK, transcriptional regulators of anabolic genes |
What Is GO:0009058?
GO:0009058 biosynthetic process is defined as a cellular process consisting of the biochemical pathways by which a living organism synthesizes chemical substances. It typically represents the energy-requiring part of metabolism in which simpler substances are transformed into more complex ones. Synonyms include anabolism, biosynthesis, formation, multicellular organismal biosynthetic process, single-organism biosynthetic process, and synthesis. This term captures the constructive side of metabolism, as opposed to catabolic processes that break down molecules.
Why Is biosynthetic process Important in Cell Biology?
Biosynthetic process is essential for all living organisms because it provides the building blocks for cellular growth, proliferation, and maintenance. In humans, dysregulated biosynthesis contributes to cancer, metabolic disorders, and neurodegenerative diseases. In biotechnology, harnessing biosynthetic pathways enables the sustainable production of valuable compounds such as antimalarial drugs. Therefore, understanding the genes, mechanisms, and regulation of biosynthetic process is critical for both basic research and therapeutic development.
• Biosynthetic process supplies nucleotides, amino acids, lipids, and other macromolecules required for cell division and growth.
• Cancer cells frequently upregulate biosynthetic pathways to support rapid proliferation, making them targets for anticancer therapy.
• Metabolic diseases such as type 2 diabetes involve altered gluconeogenesis, a key biosynthetic process.
• Protein folding, a biosynthetic process, is assisted by molecular chaperones and is linked to proteostasis diseases.
• Biosynthetic engineering enables the production of complex natural products like artemisinin in heterologous hosts.
• Eicosanoid biosynthesis is critical for skin wound healing and inflammation resolution.
• UCHL3-mediated deubiquitination of PKM2 augments cuproptosis in hepatocellular carcinoma, linking biosynthetic metabolism to cell death.
• Salidroside production via cascade biocatalysis demonstrates the industrial potential of biosynthetic enzymes.
• Understanding biosynthetic regulation can inform precision medicine and metabolic engineering strategies.
What Happens During biosynthetic process?
Precursor supply and energy input
In simple terms: Cells first gather simple building blocks and spend energy to activate them.
Biosynthetic process begins with the acquisition of simple precursors such as glucose, amino acids, and nucleotides, which are often derived from catabolic pathways. Energy in the form of ATP and reducing equivalents like NADPH is required to drive the synthesis of more complex molecules. For example, gluconeogenesis, a biosynthetic process, consumes ATP and NADH to convert pyruvate and lactate into glucose, and its flux is altered in metabolic diseases. In cancer, biosynthetic pathways are rewired to support proliferation, often relying on increased nutrient uptake and altered flux through key enzymes.
Enzymatic assembly of complex molecules
In simple terms: Enzymes stitch simple molecules together into larger, more complex products.
Once precursors are available, a series of enzymatic reactions catalyze the stepwise assembly of complex molecules. This includes the synthesis of amino acids, nucleotides, lipids, and secondary metabolites. For instance, the semi-synthetic production of artemisinin involves the engineering of yeast to produce artemisinic acid, a precursor that is chemically converted to the antimalarial drug. Similarly, cascade biocatalysis with a thermostability-enhanced UDP-glycosyltransferase enables the production of salidroside, a glycoside with pharmacological activity. These examples highlight the versatility of biosynthetic enzymes in generating diverse chemical structures.
Protein folding and maturation
In simple terms: Newly made proteins must fold into the right shape to function, often with help from chaperones.
For proteinaceous products, biosynthetic process extends to the folding and maturation of polypeptides. Biosynthetic protein folding is a spontaneous process guided by the amino acid sequence, but it is often assisted by molecular chaperones that prevent aggregation and ensure native structure formation. The process of biosynthetic protein folding determines the rapid formation of native structure, as shown in studies on model proteins. Defects in this process can lead to protein misfolding diseases, underscoring the importance of chaperone-mediated folding in biosynthetic pathways.
Regulation and integration with cellular state
In simple terms: The cell adjusts biosynthesis based on its needs and environmental cues.
Biosynthetic process is tightly regulated to balance energy consumption with cellular demands. Key signaling pathways such as mTOR and AMPK sense nutrient and energy status to modulate anabolic flux. In cancer, oncogenic signaling drives constitutive biosynthesis to support growth, while tumor suppressors may restrain it. In metabolic disease, hormonal signals influence gluconeogenesis flux, contributing to hyperglycemia. Additionally, eicosanoid biosynthesis is dynamically regulated during skin wound healing, illustrating how biosynthetic pathways respond to physiological cues. Thus, regulation ensures that biosynthesis is coordinated with cell growth, proliferation, and stress responses.
Key Genes Involved in GO:0009058 biosynthetic process
The following genes and proteins are representative players in biosynthetic process, spanning metabolic enzymes, chaperones, and regulatory factors.
| Gene | Major Role | Research Relevance |
|---|---|---|
| PCK1 | Phosphoenolpyruvate carboxykinase 1, rate-limiting in gluconeogenesis | Metabolic disease, type 2 diabetes |
| G6PC | Glucose-6-phosphatase, catalyzes final step of gluconeogenesis | Gluconeogenesis flux regulation |
| PKM2 | Pyruvate kinase M2, regulates biosynthetic metabolism in cancer | Hepatocellular carcinoma, cuproptosis |
| UCHL3 | Deubiquitinase that stabilizes PKM2 | Cancer metabolism, cuproptosis |
| HSPA1A | Heat shock protein 70, chaperone in protein folding | Biosynthetic protein folding |
| HSP60 | Chaperonin, assists mitochondrial protein folding | Proteostasis, biosynthetic folding |
| UGT | UDP-glycosyltransferase, catalyzes glycosylation in biosynthesis | Salidroside production |
| CYP71AV1 | Cytochrome P450, artemisinic acid biosynthesis | Artemisinin semi-synthesis |
| ADS | Amorpha-4,11-diene synthase, artemisinin pathway | Artemisinin production |
| PTGS2 | Cyclooxygenase-2, eicosanoid biosynthesis | Skin wound healing, inflammation |
| ALOX5 | Arachidonate 5-lipoxygenase, leukotriene biosynthesis | Eicosanoid biosynthesis |
| FASN | Fatty acid synthase, de novo lipogenesis | Cancer metabolism |
| ACACA | Acetyl-CoA carboxylase, fatty acid synthesis | Biosynthetic flux |
| GLS | Glutaminase, glutamine metabolism for biosynthesis | Cancer metabolism |
| IDH1 | Isocitrate dehydrogenase, produces NADPH for biosynthesis | Cancer metabolism |
| MTHFD2 | Methylenetetrahydrofolate dehydrogenase, one-carbon metabolism | Nucleotide biosynthesis |
| SHMT2 | Serine hydroxymethyltransferase, one-carbon metabolism | Biosynthetic support |
How Is biosynthetic process Regulated?
Biosynthetic process is regulated at multiple levels, including transcriptional control of anabolic genes, allosteric regulation of enzymes, and signaling pathways that sense nutrient and energy status. The mTOR pathway promotes biosynthesis by activating transcription factors and ribosomal biogenesis, while AMPK inhibits anabolic processes under low-energy conditions. In cancer, oncogenes such as MYC and KRAS drive biosynthetic gene expression, whereas tumor suppressors like p53 can restrain it. Hormonal regulation of gluconeogenesis, involving insulin and glucagon, controls glucose production in the liver. Additionally, feedback inhibition by end products and post-translational modifications of enzymes fine-tune biosynthetic flux. Chaperone expression is also regulated by heat shock factors to maintain proteostasis during biosynthetic demand.
biosynthetic process and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| PCK1 | Type 2 diabetes, gluconeogenesis dysregulation | Knockout mouse, point mutation for enzyme activity |
| PKM2 | Hepatocellular carcinoma, cuproptosis | Knockout cell line, overexpression for metabolic flux |
| UCHL3 | Cancer metabolism, deubiquitination | Knockout, point mutation of catalytic cysteine |
| HSPA1A | Protein misfolding, neurodegeneration | Knock-in of chaperone mutations, overexpression |
| PTGS2 | Skin wound healing, inflammation | Knockout mouse, knock-in reporter for expression |
Cancer metabolism
Cancer cells reprogram biosynthetic pathways to support rapid proliferation, including increased nucleotide, amino acid, and lipid synthesis. This metabolic rewiring is often driven by oncogenic signaling and provides targets for therapeutic intervention. For example, PKM2 deubiquitination by UCHL3 augments cuproptosis in hepatocellular carcinoma, linking biosynthetic metabolism to cell death pathways.
Metabolic disorders
Dysregulated gluconeogenesis contributes to hyperglycemia in type 2 diabetes and other metabolic diseases. Understanding the flux through biosynthetic pathways is essential for developing treatments that modulate glucose production.
Protein misfolding diseases
Defects in biosynthetic protein folding can lead to aggregation and neurodegeneration. Molecular chaperones play a protective role, and their dysfunction is implicated in various proteostasis-related diseases.
Inflammatory and wound healing disorders
Eicosanoid biosynthesis is critical for skin wound healing, and its dysregulation can lead to chronic inflammation or impaired tissue repair.
From biosynthetic process-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of a biosynthetic gene impair tumor growth? | CRISPR knockout in cancer cell lines and xenografts |
| Does a point mutation in an enzyme alter biosynthetic flux? | CRISPR point mutation knock-in in isogenic cell lines |
| Can a biosynthetic pathway be rewired by overexpression? | CRISPR overexpression (CRISPRa) or cDNA overexpression |
| How does a tagged biosynthetic protein localize? | Knock-in of fluorescent or epitope tags |
| What is the metabolic impact of a regulatory mutation? | Knock-in of phospho-mimetic or phospho-dead mutants |
| Can biosynthetic genes be screened for drug targets? | CRISPR library screening with metabolic readouts |
How to Study the biosynthetic process Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Metabolic flux analysis | Flux through biosynthetic pathways | Gluconeogenesis in diabetes, cancer metabolism |
| Proteomics | Protein abundance and modifications | Chaperone expression, enzyme regulation |
| RNA-seq | Transcriptional changes in biosynthetic genes | Cancer metabolic reprogramming |
| CRISPR screening | Gene essentiality for biosynthesis | Identifying drug targets |
| Enzyme activity assay | Catalytic rate of biosynthetic enzymes | Biocatalysis optimization |
| Isotope tracing | Metabolite labeling patterns | Pathway flux quantification |
| Western blot | Protein expression and phosphorylation | Signaling regulation of biosynthesis |
| Immunofluorescence | Subcellular localization of biosynthetic enzymes | Protein folding and trafficking |
Metabolic flux analysis
Metabolic flux analysis using stable isotope tracers (e.g., 13C-glucose, 13C-glutamine) measures the flow of metabolites through biosynthetic pathways. This technique is essential for quantifying gluconeogenesis flux in metabolic disease and cancer metabolism studies.
Proteomics and interactomics
Mass spectrometry-based proteomics can identify and quantify enzymes involved in biosynthetic process, as well as their post-translational modifications. Interactomics reveals protein-protein interactions, such as chaperone-client relationships in biosynthetic protein folding.
Transcriptomics and CRISPR screening
RNA-seq and CRISPR library screening enable systematic interrogation of genes required for biosynthetic process. These approaches can identify vulnerabilities in cancer cells and reveal regulatory networks controlling anabolic flux.
Enzyme activity assays and biocatalysis
In vitro enzyme assays measure catalytic activity of biosynthetic enzymes, such as UDP-glycosyltransferases for salidroside production. Cascade biocatalysis and engineered pathways are used to produce complex natural products like artemisinin.
How CRISPR Can Be Used to Study GO:0009058 biosynthetic process
Knockout
CRISPR knockout is used to delete biosynthetic genes to assess their role in cellular metabolism and disease. For example, knocking out UCHL3 in hepatocellular carcinoma cells can reveal its impact on PKM2 stability and cuproptosis. Knockout of PCK1 or G6PC can model gluconeogenesis defects in metabolic disease.
Point Mutation
CRISPR point mutation introduces specific amino acid changes to dissect catalytic or regulatory functions of biosynthetic enzymes. This is valuable for studying enzyme active sites, such as the catalytic cysteine of UCHL3, or phosphorylation sites in metabolic regulators.
Knock-in
Knock-in of tags or reporters allows visualization and quantification of biosynthetic proteins in their native context. For instance, knocking in a fluorescent tag on a chaperone can track its localization during protein folding. Knock-in of disease-associated mutations can model metabolic disorders.
Overexpression
CRISPR activation (CRISPRa) or cDNA overexpression is used to increase expression of biosynthetic genes to study pathway flux and metabolic rewiring. Overexpression of PKM2 or UCHL3 can enhance biosynthetic metabolism and alter cell death responses. Overexpression of biosynthetic enzymes in microbial hosts enables production of natural products like artemisinin.
How EDITGENE Supports biosynthetic process Research
Researchers studying biosynthetic process-related genes often need to determine whether a candidate gene is causally involved in metabolic rewiring, disease progression, or drug response. EDITGENE provides comprehensive CRISPR-based services to generate precisely engineered cell models, enabling functional validation of biosynthetic genes in physiologically relevant contexts.
Contact EDITGENE today to design your custom CRISPR model for biosynthetic process research.
Frequently Asked Questions About biosynthetic process
What is GO:0009058 biosynthetic process?
GO:0009058 is a Gene Ontology term describing the biochemical pathways by which organisms synthesize complex molecules from simpler ones, typically requiring energy. It is synonymous with anabolism and biosynthesis.
What genes are involved in biosynthetic process?
Key genes include metabolic enzymes like PCK1, G6PC, PKM2, FASN, and chaperones such as HSPA1A, as well as regulatory factors like UCHL3.
How is biosynthetic process regulated?
It is regulated by signaling pathways such as mTOR and AMPK, transcriptional programs, and feedback inhibition. Hormones like insulin and glucagon control gluconeogenesis.
Why is biosynthetic process important in cancer?
Cancer cells upregulate biosynthetic pathways to support rapid growth, making these pathways attractive therapeutic targets.
What diseases are linked to defects in biosynthetic process?
Diseases include type 2 diabetes (gluconeogenesis), cancer (metabolic reprogramming), and protein misfolding disorders (chaperone dysfunction).
How can CRISPR be used to study biosynthetic process?
CRISPR knockout, point mutation, knock-in, and overexpression enable functional dissection of biosynthetic genes in cell models.
What methods measure biosynthetic flux?
Metabolic flux analysis with stable isotopes, enzyme activity assays, and metabolomics are commonly used.
What is the role of chaperones in biosynthetic process?
Chaperones assist in the folding of newly synthesized proteins, ensuring they attain their native structure and preventing aggregation.
Can biosynthetic pathways be engineered for drug production?
Yes, engineered yeast can produce artemisinic acid, a precursor to the antimalarial artemisinin, demonstrating the industrial potential of biosynthetic engineering.
What is the difference between biosynthetic process and metabolism?
Biosynthetic process refers specifically to the anabolic, energy-requiring part of metabolism that builds complex molecules, as opposed to catabolic processes that break them down.
Conclusion
GO:0009058 biosynthetic process is a fundamental biological process that underpins cellular growth, adaptation, and disease. From cancer metabolism to metabolic disorders and biotechnology, understanding the genes, regulation, and mechanisms of biosynthesis offers vast opportunities for research and therapeutic development. CRISPR-based models and advanced analytical methods are indispensable tools for dissecting these pathways. EDITGENE's comprehensive services empower researchers to uncover causal roles of biosynthetic genes and translate findings into clinical and industrial applications.
References
- 1. Shah A et al.. 2023. Gluconeogenesis Flux in Metabolic Disease.. Annu Rev Nutr 43:153-177 PMID: 37603427
- 2. DeNicola GM et al.. 2015. Cancer's Fuel Choice: New Flavors for a Picky Eater.. Mol Cell 60(4):514-23 PMID: 26590711
- 3. Paddon CJ et al.. 2013. High-level semi-synthetic production of the potent antimalarial artemisinin.. Nature 496(7446):528-32 PMID: 23575629
- 4. Fedorov AN. 2022. Biosynthetic Protein Folding and Molecular Chaperons.. Biochemistry (Mosc) 87(Suppl 1):S128-S19 PMID: 35501992
- 5. Yao L et al.. 2025. UCHL3 augments cuproptosis via PKM2 deubiquitination in hepatocellular carcinoma.. Free Radic Biol Med 237:65-75 PMID: 40451468
- 6. Li G et al.. 2025. Salidroside production through cascade biocatalysis with a thermostability-enhanced UDP-glycosyltransferase.. Int J Biol Macromol 299:140261 PMID: 39855494
- 7. Yasukawa K et al.. 2020. Eicosanoids in Skin Wound Healing.. Int J Mol Sci 21(22) PMID: 33182690
- 8. Fedorov AN et al.. 1999. Process of biosynthetic protein folding determines the rapid formation of native structure.. J Mol Biol 294(2):579-86 PMID: 10610781
